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The Problem 
• There are an estimated 25,000-30,000 people in Maine that 
want treatment for OUD but do not have access1
• There are only 215-230 Suboxone providers in Maine, out 
of  approximately 2,000 PCPs1
• Only 30-35 PCP sites offer MAT out of  approximately 5002
• Maine has very high opioid use rate: 60.4 pills per capita in 
20142
• In 2016, Maine had 376 drug-induced deaths:3
• 84% caused by at least one opioid
• 38% increase from 2015
2
Source: Maine Attorney General 
Public Health Cost
• Nationwide, OUD related consequences have led to $56 billion in economic 
costs4
• 2010 estimated cost of  substance abuse in Maine was $1.4 billion5
• 2015 report showed Maine’s total health care cost from opioid abuse to be 
$92,736,9666
• 4.15% of  prescription pain medication is used non-medically, including 
11.29% in the 18-25 demographic7
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Community Perspective 
• Perspectives from several local providers (MDs, NP):
• “There is definitely a need, and we bear some of  the responsibility for the problem. If  there were support staff  in place to 
manage counseling, monitoring, urine drug screens etc. I would be more than willing to get waivered.”
• “Time and access are problems- I already have a waiting list of  patients.” 
• “I would need more education on how the process [Hub and Spoke] works”
• “It’s slightly insulting that mid-level providers are required 3x more training to be waivered”
• Perspectives from meeting of Downeast Substance Treatment Group
• “We have to help providers to be comfortable with Suboxone and with the system, so that when relapses happen they can be 
comfortable that the Hub will be there to support them”
• “The Suboxone waiver training was actually inspirational and encouraging – I wish there was a way to incentivize the training 
as all my concerns were addressed during it”
4
Intervention and Methodology 
• Reviewed current situation regarding Suboxone prescribing in state of  Maine
• Discussed with several community providers (MDs, NPs) their perspective 
on barriers that exist to becoming waivered to prescribe Suboxone 
• Created one page pamphlet including information on:
• State of  the problem and need for MAT
• Information on Hub-and-Spoke model 
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Hub and Spoke Model of Care 
Information for Providers 
Problem in Maine: 
• There is a major need for providers in Maine that can prescribe buprenorphine, morphine 
for Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD).  
• It is estimated that 25,000-30,000 people in Maine want treatment for OUD but do not 
have access1   
• There are only 215-230 Suboxone providers in Maine, out of approximately 2,000 PCPs1  
• In 2016, Maine had 376 drug-induced deaths:2 
o 84% caused by at least one opioid 
o 38% increase from 2015 
 
Hub-and-Spoke Model:3 
The Hub-and-Spoke model for MAT was created to bring treating patients for addiction 
disorders in line with the treatment for many other disease processes. Much like primary care 
offices work together with cardiologists to manage patients with CHF or atrial fibrillation, Hub-
and-Spoke allows local providers (spokes) to treat patients that are stable while having back-up 
and support from addiction specialists at the hubs.  
Hubs: 
• Staffed by psychiatrist available for consultation  
• Assess patients medical and psychiatric needs at intake, determine appropriate treatment 
placement  
• Bidirectional transfer to spokes  
Spokes: 
• For patients that have been deemed stabilized on MAT at the hub 
• Local providers – family practitioners, internists, psychiatrists, obstetricians, pediatricians 
• Direct access to hubs for consultations  
• Supported by MAT team- 1 RN and behavioral health provider per 100 Medicaid patients  
 
Process:  
There are many different options available for online training to receive the waiver to prescribe 
Suboxone. The requirement is one 8-hour course for MDs/DOs, and one 24-hour course for 
NPs/PAs. See below for several options:  
• American Society of Addiction Medicine 
o Apply online: http://buprenorphine.samhsa.gov/forms/select-practitioner-type.php   
o Mobile App: http://store.samhsa.gov/apps/mat/  
o Resources: https://www.asam.org/education/live-online-cme/buprenorphine-
course/content-handouts 
• Providers’ Clinical Support System for Medication Assisted Treatment 
o Apply online: http://pcssmat.org/education-training/mat-waiver-training/  
o Free training for MDs/DOs/NPs/PAs  
o Offers many other CME courses, webinars, mentorship for MAT 
• American Academy of Addiction Psychiatry  
o Apply online: http://www.aaap.org/education-training/buprenorphine/   
o $124 for members, $196 for non-members 
Evaluation of  Effectiveness/Limitations
• This pamphlet was meant to be an educational/informational source for providers considering obtaining 
waivers for prescription of Suboxone. 
• It was well received by the leaders of the Downeast Substance Treatment Group and Maine Coast Memorial 
Hospital associated PCPs at their weekly meeting
• Evaluating effectiveness of pamphlet could include:
• Monitoring what clinics receive pamphlet and how rates of  obtaining Suboxone waiver compare to clinics that do not receive 
pamphlet
• The overall goal is to increase the number of  Suboxone providers in this region, so seeing an actual increase would be a good
measure of  effectiveness 
• Limitations include:
• Only addressing the process of  getting waivered, there is need for education on how the entire program works 
• Currently only in paper form- having electronic version will allow providers to click links to directly access training sites
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Recommendations for Future Projects 
• Future projects could delve into other barriers identified by providers 
including: 
• Need for support staff  
• Education on Hub-and-Spoke model 
• There will also certainly be challenges that come up during implementation 
of  Hub and Spoke in Maine that will need to be addressed, including:
• Patient access to counseling 
• Patient awareness of  program 
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